Joel Greenblatt fit · Magic Formula - high ROIC + cheap EV/EBIT
Is Krystal Biotech, Inc. (KRYS) a Joel Greenblatt Stock?
Partial match - either cheap or high-quality, but not both.
59/100
CMixed signals
1/5 criteria passed
+8 sector-quality lift. Top-quintile within its sector on 4 of 5 quality metrics. Raw pillar score 51 → lifted to 59 before grade derivation.
Joel Greenblatt's Criteria, Applied to KRYS
EBIT/EV yield ≥ 10%
key1.9%
ROIC ≥ 25%
key13.9%
EV/EBIT ≤ 12
52.9x
Gross margin ≥ 30%
92.8%
How KRYS Scores on Other Strategies
Live Financial Snapshot
Market cap
$10.27B
P/E (TTM)
39.9x
ROIC (TTM)
13.85%
Gross margin
92.79%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is KRYS's Joel Greenblatt fit score?
KRYS scores 59/100 on our Joel Greenblatt fit engine - grade C. Partial match - either cheap or high-quality, but not both.
Does Joel Greenblatt actually own KRYS?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends KRYS.
How often is this score updated?
KRYS's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends KRYS.